WESTLAKE VILLAGE, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD),
focused on the discovery and development of therapeutic products for patients with diseases such as diabetes, announced today that
it will present at upcoming conferences.
- Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 9:35 am (ET) at the
Lotte New York Palace in New York
- Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 9:10 am (ET) at the InterContinental New York
Barclay Hotel in New York
Presenting from the Company will be its Chief Executive Officer, Michael Castagna.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of
the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients
with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases
as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that
are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts
certain other information to the website.
Company Contact: Rose Alinaya SVP Investor Relations 818-661-5055 ir@mannkindcorp.com
